SynthesisDiabetes research and clinical practice2023

Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression.

Hikmat Permana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.